Joseph Catanzaro
Stock Analyst at Mizuho Securities
(4.65)
# 878
Out of 5,118 analysts
411
Total ratings
45.8%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Joseph Catanzaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Rated: Hold | n/a | $6.93 | - | 4 | Sep 4, 2026 | |
| BCAX Bicara Therapeutics | Rated: Hold | n/a | $8.65 | - | 3 | Sep 4, 2026 | |
| CLDX Celldex Therapeutics | Rated: Hold | n/a | $29.87 | - | 4 | Sep 4, 2026 | |
| ERAS Erasca | Rated: Hold | n/a | $14.41 | - | 5 | Sep 4, 2026 | |
| KYMR Kymera Therapeutics | Rated: Hold | n/a | $131.73 | - | 4 | Sep 4, 2026 | |
| NRIX Nurix Therapeutics | Rated: Hold | n/a | $15.30 | - | 28 | Sep 4, 2026 | |
| RVMD Revolution Medicines | Rated: Hold | n/a | $192.28 | - | 18 | Sep 4, 2026 | |
| SYRE Spyre Therapeutics | Rated: Hold | n/a | $103.86 | - | 5 | Sep 4, 2026 | |
| TNGX Tango Therapeutics | Rated: Hold | n/a | $21.50 | - | 10 | Sep 4, 2026 | |
| UPB Upstream Bio | Rated: Hold | n/a | $3.23 | - | 3 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $36 | $9.25 | +289.19% | 2 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $9.62 | +419.75% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $10.29 | +74.93% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $5.90 | +340.68% | 1 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.5 | $0.1935 | n/a | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $38 | $3.50 | n/a | 5 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.25 | $2.19 | n/a | 15 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 | $103.63 | n/a | 27 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.75 → $4.25 | $8.64 | n/a | 15 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.7953 | n/a | 16 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 → $6 | $8.04 | n/a | 37 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $45 | $29.82 | n/a | 5 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $38 | $69.57 | n/a | 11 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $110 | $166.89 | n/a | 20 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $3 | $2.88 | n/a | 15 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $15 | $9.36 | n/a | 25 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 | $6.36 | n/a | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $19 | $0.5668 | n/a | 17 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 | $1.74 | n/a | 10 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $1.61 | n/a | 8 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $0.9095 | n/a | 9 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $1.75 | $3.13 | n/a | 9 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $2.46 | n/a | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.60 | n/a | 39 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1.75 | $0.7287 | n/a | 4 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $0.8928 | n/a | 3 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $25.31 | n/a | 4 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $4 | $22.05 | n/a | 4 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $36 | $19.82 | n/a | 4 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $0.9377 | n/a | 7 | Aug 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $18 | $1.89 | n/a | 4 | Apr 7, 2020 |
Avalo Therapeutics
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $6.93
Upside: -
Bicara Therapeutics
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $8.65
Upside: -
Celldex Therapeutics
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $29.87
Upside: -
Erasca
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $14.41
Upside: -
Kymera Therapeutics
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $131.73
Upside: -
Nurix Therapeutics
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $15.30
Upside: -
Revolution Medicines
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $192.28
Upside: -
Spyre Therapeutics
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $103.86
Upside: -
Tango Therapeutics
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $21.50
Upside: -
Upstream Bio
Sep 4, 2026
Rated: Hold
Price Target: n/a
Current: $3.23
Upside: -
Jul 13, 2026
Reiterated: Buy
Price Target: $14 → $36
Current: $9.25
Upside: +289.19%
Apr 30, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $9.62
Upside: +419.75%
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $10.29
Upside: +74.93%
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $5.90
Upside: +340.68%
Mar 21, 2025
Reiterated: Buy
Price Target: $4.5
Current: $0.1935
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $36 → $38
Current: $3.50
Upside: n/a
Mar 7, 2025
Reiterated: Buy
Price Target: $3.25
Current: $2.19
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $53
Current: $103.63
Upside: n/a
Mar 3, 2025
Reiterated: Hold
Price Target: $4.75 → $4.25
Current: $8.64
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $10
Current: $0.7953
Upside: n/a
Feb 28, 2025
Reiterated: Hold
Price Target: $7.5 → $6
Current: $8.04
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $50 → $45
Current: $29.82
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $37 → $38
Current: $69.57
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $105 → $110
Current: $166.89
Upside: n/a
Jan 29, 2025
Rated: Buy
Price Target: $15 → $3
Current: $2.88
Upside: n/a
Jan 17, 2025
Reiterated: Buy
Price Target: $40 → $15
Current: $9.36
Upside: n/a
Nov 6, 2024
Rated: Buy
Price Target: $19
Current: $6.36
Upside: n/a
Oct 31, 2024
Reiterated: Buy
Price Target: $10 → $19
Current: $0.5668
Upside: n/a
Oct 8, 2024
Rated: Buy
Price Target: $15
Current: $1.74
Upside: n/a
Sep 16, 2024
Rated: Buy
Price Target: $30
Current: $1.61
Upside: n/a
Sep 16, 2024
Reiterated: Buy
Price Target: $10 → $8
Current: $0.9095
Upside: n/a
Aug 27, 2024
Downgraded: Hold
Price Target: $5 → $1.75
Current: $3.13
Upside: n/a
Apr 22, 2024
Initiated Coverage: Buy
Price Target: $20
Current: $2.46
Upside: n/a
Apr 8, 2024
Reiterated: Buy
Price Target: $15
Current: $6.60
Upside: n/a
Sep 14, 2022
Reiterated: Hold
Price Target: $1.5 → $1.75
Current: $0.7287
Upside: n/a
May 31, 2022
Reiterated: Buy
Price Target: $15
Current: $0.8928
Upside: n/a
May 31, 2022
Reiterated: Buy
Price Target: $6
Current: $25.31
Upside: n/a
May 12, 2022
Reiterated: Buy
Price Target: $10 → $4
Current: $22.05
Upside: n/a
Mar 9, 2022
Reiterated: Buy
Price Target: $45 → $36
Current: $19.82
Upside: n/a
Aug 21, 2020
Reiterated: Buy
Price Target: $15 → $17
Current: $0.9377
Upside: n/a
Apr 7, 2020
Reiterated: Buy
Price Target: $28 → $18
Current: $1.89
Upside: n/a